Intravoxel incoherent motion imaging kinetics during chemoradiotherapy for human papillomavirus-associated squamous cell carcinoma of the oropharynx: Preliminary results from a prospective pilot study

NMR in Biomedicine

Volumn 28, Issue 12, 2015, Pages 1645-1654

  Ding, Yao ^a   Hazle, John D ^a   Mohamed, Abdallah S R ^a,b   Frank, Steven J ^a   Hobbs, Brian P ^a   Colen, Rivka R ^a   Gunn, G Brandon ^a   Wang, Jihong ^a   Kalpathy Cramer, Jayashree ^c   Garden, Adam S ^a   Lai, Stephen Y ^a   Rosenthal, David I ^a   Fuller, Clifton D ^a,d  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b ALEXANDRIA UNIVERSITY   (Egypt)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

Chemoradiotherapy; HPV associated oropharyngeal cancer; Intravoxel incoherent motion imaging; Response assessment

Indexed keywords

CHEMORADIOTHERAPY; DIFFUSION; DISCRIMINANT ANALYSIS; FORECASTING; MOTION ANALYSIS; MULTIVARIANT ANALYSIS; STATISTICAL METHODS; SURFACE DIFFUSION;

APPARENT DIFFUSION COEFFICIENT; INSTITUTIONAL REVIEW BOARDS; INTRAVOXEL INCOHERENT MOTIONS; LEAVE-ONE-OUT CROSS VALIDATIONS; OROPHARYNGEAL CANCER; PSEUDO DIFFUSION COEFFICIENTS; QUADRATIC DISCRIMINANT ANALYSIS; RESPONSE ASSESSMENT;

PATIENT TREATMENT;

CARBOPLATIN; CETUXIMAB; CISPLATIN; DOCETAXEL;

ADULT; AGED; ARTICLE; CHEMORADIOTHERAPY; CLINICAL ARTICLE; DIFFUSION COEFFICIENT; FEMALE; GENERAL MEDICAL DEVICE; HUMAN; IMAGE ANALYSIS; INTENSITY MODULATED RADIATION THERAPY; INTRAVOXEL INCOHERENT MOTION IMAGING; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OROPHARYNX CARCINOMA; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TREATMENT RESPONSE; WART VIRUS; CARCINOMA, SQUAMOUS CELL; COMPLICATION; COMPUTER ASSISTED DIAGNOSIS; HEAD AND NECK NEOPLASMS; KINETICS; MOTION; OROPHARYNGEAL NEOPLASMS; OUTCOME ASSESSMENT; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; THREE DIMENSIONAL IMAGING; TREATMENT OUTCOME;

CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; HEAD AND NECK NEOPLASMS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; KINETICS; MAGNETIC RESONANCE IMAGING; MOTION; OROPHARYNGEAL NEOPLASMS; OUTCOME ASSESSMENT (HEALTH CARE); PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84954391833     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.3412     Document Type: Article

References (48)

1. Dawson LA, Anzai Y, Marsh L, Martel MK, Paulino A, Ship JA, Eisbruch A. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 2000; 46(5): 1117-1126.
2. Chao KS, Ozyigit G, Tran BN, Cengiz M, Dempsey JF, Low DA. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 2003; 55(2): 312-321.
3. Bentzen SM, Gregoire V. Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription. Semin. Radiat. Oncol. 2011; 21(2): 101-110.
4. Dirix P, Vandecaveye V, De Keyzer F, Stroobants S, Hermans R, Nuyts S. Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with F-18-FDG PET, F-18-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI. J. Nucl. Med 2009; 50(7): 1020-1027.
5. Johansen R, Jensen LR, Rydand J, Goa PE, Kvistad KA, Bathen TF, Axelson DE, Lundgren S, Gribbestad IS. Predicting survival and early clinical response to primary chemotherapy for patients with locally advanced breast cancer using DCE-MRI. J. Magn. Reson. Imaging 2009; 29(6): 1300-1307.
6. Patterson DM, Padhani AR, Collins DJ. Technology insight: water diffusion MRI - a potential new biomarker of response to cancer therapy. Nat. Clin. Pract. Oncol. 2008; 5(4): 220-233.
7. Thoeny HC, Ross BD. Predicting and monitoring cancer treatment response with diffusion-weighted MRI. J. Magn. Reson. Imaging 2010; 32(1): 2-16.
8. Vandecaveye V, De Keyzer F, Nuyts S, Deraedt K, Dirix P, Hamaekers P, Vander Poorten V, Delaere P, Hermans R. Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. Int. J. Radiat. Oncol. Biol. Phys. 2007; 67(4): 960-971.
9. Kim S, Loevner L, Quon H, Sherman E, Weinstein G, Kilger A, Poptani H. Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin. Cancer Res. 2009; 15(3): 986-994.
10. Vandecaveye V, Dirix P, De Keyzer F, de Beeck KO, Vander Poorten V, Roebben I, Nuyts S, Hermans R. Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma. Eur. Radiol. 2010; 20(7): 1703-1714.
11. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988; 168(2): 497-505.
12. Le Bihan D. Intravoxel incoherent motion perfusion MR imaging: a wake-up call. Radiology 2008; 249(3): 748-752.
13. Sigmund EE, Cho GY, Kim S, Finn M, Moccaldi M, Jensen JH, Sodickson DK, Goldberg JD, Formenti S, Moy L. Intravoxel incoherent motion imaging of tumor microenvironment in locally advanced breast cancer. Magn. Reson. Med. 2011; 65(5): 1437-1447.
14. Kim T, Kim SG. Quantification of cerebral arterial blood volume using arterial spin labeling with intravoxel incoherent motion-sensitive gradients. Magn. Reson. Med. 2006; 55(5): 1047-1057.
15. Federau C, Maeder P, O'Brien K, Browaeys P, Meuli R, Hagmann P. Quantitative measurement of brain perfusion with intravoxel incoherent motion MR imaging. Radiology 2012; 265(3): 874-881.
16. Luciani A, Vignaud A, Cavet M, Nhieu JT, Mallat A, Ruel L, Laurent A, Deux JF, Brugieres P, Rahmouni A. Liver cirrhosis: intravoxel incoherent motion MR imaging-pilot study. Radiology 2008; 249(3): 891-899.
17. Chandarana H, Kang SK, Wong S, Rusinek H, Zhang JL, Arizono S, Huang WC, Melamed J, Babb JS, Suan EF, Lee VS, Sigmund EE. Diffusion-weighted intravoxel incoherent motion imaging of renal tumors with histopathologic correlation. Invest. Radiol. 2012; 47(12): 688-696.
18. Lemke A, Laun FB, Klauss M, Re TJ, Simon D, Delorme S, Schad LR, Stieltjes B. Differentiation of pancreas carcinoma from healthy pancreatic tissue using multiple b-values: comparison of apparent diffusion coefficient and intravoxel incoherent motion derived parameters. Invest. Radiol. 2009; 44(12): 769-775.
19. Dopfert J, Lemke A, Weidner A, Schad LR. Investigation of prostate cancer using diffusion-weighted intravoxel incoherent motion imaging. Magn. Reson. Imaging 2011; 29(8): 1053-1058.
20. Sumi M, Van Cauteren M, Sumi T, Obara M, Ichikawa Y, Nakamura T. Salivary gland tumors: use of intravoxel incoherent motion MR imaging for assessment of diffusion and perfusion for the differentiation of benign from malignant tumors. Radiology 2012; 263(3): 770-777.
21. Hauser T, Essig M, Jensen A, Gerigk L, Laun FB, Munter M, Simon D, Stieltjes B. Characterization and therapy monitoring of head and neck carcinomas using diffusion-imaging-based intravoxel incoherent motion parameters-preliminary results. Neuroradiology 2013; 55(5): 527-536.
22. Lai V, Li X, Lee VH, Lam KO, Chan Q, Khong PL. Intravoxel incoherent motion MR imaging: comparison of diffusion and perfusion characteristics between nasopharyngeal carcinoma and post-chemoradiation fibrosis. Eur. Radiol. 2013; 23(10): 2793-2801.
23. Lu Y, Jansen JF, Stambuk HE, Gupta G, Lee N, Gonen M, Moreira A, Mazaheri Y, Patel SG, Deasy JO, Shah JP, Shukla-Dave A. Comparing primary tumors and metastatic nodes in head and neck cancer using intravoxel incoherent motion imaging: a preliminary experience. J. Comput. Assisted Tomogr 2013; 37(3): 346-352.
24. Marzi S, Piludu F, Vidiri A. Assessment of diffusion parameters by intravoxel incoherent motion MRI in head and neck squamous cell carcinoma. NMR Biomed 2013; 26(12): 1806-1814.
25. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML. Human papillomavirus and survival of patients with oropharyngeal cancer. N. Engl. J. Med. 2010; 363(1): 24-35.
26. Hong AM, Dobbins TA, Lee CS, Jones D, Harnett GB, Armstrong BK, Clark JR, Milross CG, Kim J, O'Brien CJ, Rose BR. Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy. Br. J. Cancer 2010; 103(10): 1510-1517.
27. Hauser T, Essig M, Jensen A, Laun FB, Munter M, Maier-Hein KH, Stieltjes B. Prediction of treatment response in head and neck carcinomas using IVIM-DWI: evaluation of lymph node metastasis. Eur. J. Radiol 2014; 83(5): 783-787.
28. Bhatia KSS, King AD, Yu KH, Vlantis AC, Tse GM, Mo FK, Ahuja AT. Does primary tumour volumetry performed early in the course of definitive concomitant chemoradiotherapy for head and neck squamous cell carcinoma improve prediction of primary site outcome? Br. J. Radiol. 2010; 83(995): 964-970.
29. Lee H, Ahn YC, Oh D, Nam H, Kim YI, Park SY. Tumor volume reduction rate measured during adaptive definitive radiation therapy as a potential prognosticator of locoregional control in patients with oropharyngeal cancer. Head Neck J. Sci. Spec. 2014; 36(4): 499-504.
30. Hermans R. Head and neck cancer: how imaging predicts treatment outcome. Cancer Imaging 2006; 6: S145-S153.
31. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur. J. Cancer 2009; 45(2): 228-247.
32. Frank SJ. Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT). ClinicalTrials.gov Identifier: NCT01893307. Available at: https://clinicaltrials.gov/ct2/show/NCT01893307?term=head+neck+frank&rank=2, M. D. Anderson Cancer Center [accessed 13 June 2014].
33. Ding Y, Mohamed AS, Yang J, Colen RR, Frank SJ, Wang J, Wassal EY, Wang W, Kantor ME, Balter PA, Rosenthal DI, Lai SY, Hazle JD, Fuller CD. Prospective observer and software-based assessment of magnetic resonance imaging quality in head and neck cancer: should standard positioning and immobilization be required for radiation therapy applications? Pract. Radiat. Oncol. 2015; 5(4): e299-e308.
34. Sumi M, Nakamura T. Head and neck tumors: assessment of perfusion-related parameters and diffusion coefficients based on the intravoxel incoherent motion model. Am. J. Neuroradiol. 2013; 34(2): 410-416.
35. Srivastava S, Gupta MR, Frigyik BA. Bayesian quadratic discriminant analysis. J. Mach. Learn Res. 2007; 8: 1277-1305.
36. Akaike H. New look at statistical-model identification. IEEE Trans. Automat. Contr. 1974; Ac19(6): 716-723.
37. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44(3): 837-845.
38. Nam H, Park W, Huh SJ, Bae DS, Kim BG, Lee JH, Lee JW, Lim DH, Han Y, Park HC, Ahn YC. The prognostic significance of tumor volume regression during radiotherapy and concurrent chemoradiotherapy for cervical cancer using MRI. Gynecol. Oncol. 2007; 107(2): 320-325.
39. Bral S, De Ridder M, Duchateau M, Gevaert T, Engels B, Schallier D, Storme G. Daily megavoltage computed tomography in lung cancer radiotherapy: correlation between volumetric changes and local outcome. Int. J. Radiat. Oncol. 2011; 80(5): 1338-1342.
40. Jaulerry C, Dubray B, Brunin F, Rodriguez J, Point D, Blaszka B, Asselain B, Mosseri V, Brugere J, Cosset JM. Prognostic value of tumor regression during radiotherapy for head and neck cancer: a prospective study. Int. J. Radiat. Oncol. Biol. Phys. 1995; 33(2): 271-279.
41. Le Bihan D, Turner R, Moonen CT, Pekar J. Imaging of diffusion and microcirculation with gradient sensitization: design, strategy, and significance. J. Magn. Reson. Imaging 1991; 1(1): 7-28.
42. Pekar J, Moonen CT, van Zijl PC. On the precision of diffusion/ perfusion imaging by gradient sensitization. Magn. Reson. Med. 1992; 23(1): 122-129.
43. Neil JJ, Bretthorst GL. On the use of Bayesian probability theory for analysis of exponential decay data: an example taken from intravoxel incoherent motion experiments. Magn. Reson. Med. 1993; 29(5): 642-647.
44. Hauser T, Essig M, Jensen A, Laun FB, Munter M, Maier-Hein KH, Stieltjes B. Prediction of treatment response in head and neck carcinomas using IVIM-DWI: evaluation of lymph node metastasis. Eur. J. Radiol 2014; 83(5): 783-787.
45. Hatakenaka M, Nakamura K, Yabuuchi H, Shioyama Y, Matsuo Y, Ohnishi K, Sunami S, Kamitani T, Setoguchi T, Yoshiura T, Nakashima T, Nishikawa K, Honda H. Pretreatment apparent diffusion coefficient of the primary lesion correlates with local failure in head-and-neck cancer treated with chemoradiotherapy or radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2011; 81(2): 339-345.
46. Schakel T, Hoogduin JM, Terhaard CH, Philippens ME. Diffusion weighted MRI in head-and-neck cancer: geometrical accuracy. Radiother. Oncol. 2013; 109(3): 394-397.
47. Pipe JG, Farthing VG, Forbes KP. Multishot diffusion-weighted FSE using PROPELLER MRI. Magn. Reson. Med. 2002; 47(1): 42-52.
48. Sakamoto J, Imaizumi A, Sasaki Y, Kamio T, Wakoh M, Otonari-Yamamoto M, Sano T. Comparison of accuracy of intravoxel incoherent motion and apparent diffusion coefficient techniques for predicting malignancy of head and neck tumors using half-Fourier single-shot turbo spin-echo diffusion-weighted imaging. Magn. Reson. Imaging 2014; 32(7): 860-866.